Cargando…

A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease

Despite the ubiquity of the Boston naming test (BNT) in clinical practice and research, concerns have been expressed about its poor quality pictures, insufficient psychometric properties, and cultural bias in non-English language backgrounds. We modified the black-and-white BNT with a set of color p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan, Yu, Yue-Yi, Hu, Nan, Zhang, Min, Liu, Li, Fan, Li-Mei, Ruan, Shi-Shuang, Wang, Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082938/
https://www.ncbi.nlm.nih.gov/pubmed/35547369
http://dx.doi.org/10.3389/fneur.2022.884460
_version_ 1784703311468822528
author Li, Dan
Yu, Yue-Yi
Hu, Nan
Zhang, Min
Liu, Li
Fan, Li-Mei
Ruan, Shi-Shuang
Wang, Fen
author_facet Li, Dan
Yu, Yue-Yi
Hu, Nan
Zhang, Min
Liu, Li
Fan, Li-Mei
Ruan, Shi-Shuang
Wang, Fen
author_sort Li, Dan
collection PubMed
description Despite the ubiquity of the Boston naming test (BNT) in clinical practice and research, concerns have been expressed about its poor quality pictures, insufficient psychometric properties, and cultural bias in non-English language backgrounds. We modified the black-and-white BNT with a set of color pictures since color effects have been suggested to improve naming accuracy in the visual naming test. This study aimed to examine and compare the reliability and validity of the color-picture version of BNT (CP-BNT) and the black-and-white version of BNT (BW-BNT) to differentiate amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD) from the cognitive normals. This study included two subgroups, and each subgroup had 101 normal controls, 51 aMCI, and 52 mild AD. One subgroup undertook BW-BNT and the other conducted CP-BNT. The reliability, convergent and discriminant validity, and the diagnostic accuracy of two versions of BNT were evaluated. The CP-BNT showed a greater area under the curve (AUC) than the BW-BNT for aMCI (80.3 vs.s 69.4%) and mild AD (93.5 vs. 77.6%). The CP-BNT also demonstrated better convergent validity with CDR global scores and better reliability (Cronbach's coefficient 0.66 for the CP-BNT vs. 0.55 for the BW-BNT). At the optimal cutoff value of spontaneous naming, the CP-BNT demonstrated improved sensitivity and specificity for differentiating mild AD from NC with a higher positive predictive value, negative predictive value, and lower false-positive rate. Compared with BW-BNT, CP-BNT is a more reliable and valid test to assess cognitive and naming impairment.
format Online
Article
Text
id pubmed-9082938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90829382022-05-10 A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Li, Dan Yu, Yue-Yi Hu, Nan Zhang, Min Liu, Li Fan, Li-Mei Ruan, Shi-Shuang Wang, Fen Front Neurol Neurology Despite the ubiquity of the Boston naming test (BNT) in clinical practice and research, concerns have been expressed about its poor quality pictures, insufficient psychometric properties, and cultural bias in non-English language backgrounds. We modified the black-and-white BNT with a set of color pictures since color effects have been suggested to improve naming accuracy in the visual naming test. This study aimed to examine and compare the reliability and validity of the color-picture version of BNT (CP-BNT) and the black-and-white version of BNT (BW-BNT) to differentiate amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD) from the cognitive normals. This study included two subgroups, and each subgroup had 101 normal controls, 51 aMCI, and 52 mild AD. One subgroup undertook BW-BNT and the other conducted CP-BNT. The reliability, convergent and discriminant validity, and the diagnostic accuracy of two versions of BNT were evaluated. The CP-BNT showed a greater area under the curve (AUC) than the BW-BNT for aMCI (80.3 vs.s 69.4%) and mild AD (93.5 vs. 77.6%). The CP-BNT also demonstrated better convergent validity with CDR global scores and better reliability (Cronbach's coefficient 0.66 for the CP-BNT vs. 0.55 for the BW-BNT). At the optimal cutoff value of spontaneous naming, the CP-BNT demonstrated improved sensitivity and specificity for differentiating mild AD from NC with a higher positive predictive value, negative predictive value, and lower false-positive rate. Compared with BW-BNT, CP-BNT is a more reliable and valid test to assess cognitive and naming impairment. Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9082938/ /pubmed/35547369 http://dx.doi.org/10.3389/fneur.2022.884460 Text en Copyright © 2022 Li, Yu, Hu, Zhang, Liu, Fan, Ruan and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Li, Dan
Yu, Yue-Yi
Hu, Nan
Zhang, Min
Liu, Li
Fan, Li-Mei
Ruan, Shi-Shuang
Wang, Fen
A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
title A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
title_full A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
title_fullStr A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
title_full_unstemmed A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
title_short A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
title_sort color-picture version of boston naming test outperformed the black-and-white version in discriminating amnestic mild cognitive impairment and mild alzheimer's disease
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082938/
https://www.ncbi.nlm.nih.gov/pubmed/35547369
http://dx.doi.org/10.3389/fneur.2022.884460
work_keys_str_mv AT lidan acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT yuyueyi acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT hunan acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT zhangmin acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT liuli acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT fanlimei acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT ruanshishuang acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT wangfen acolorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT lidan colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT yuyueyi colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT hunan colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT zhangmin colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT liuli colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT fanlimei colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT ruanshishuang colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease
AT wangfen colorpictureversionofbostonnamingtestoutperformedtheblackandwhiteversionindiscriminatingamnesticmildcognitiveimpairmentandmildalzheimersdisease